The content of this website is intended for healthcare professionals only

Would it be easier to just give everyone statins?

Portfolio politics

Louise Newson

24 July 2014

Add to PDP Tracker

Statins_shutterstock_3914251[1].jpgNICE has recently updated its 2006 guidelines on lipid modification and it now recommends that the threshold for starting preventative treatment for cardiovascular disease (CVD) should be halved from a 20% risk of developing CVD over 10 years to a 10% risk.

This now means that up to 4.5 million people could now be eligible for statins. It has been estimated that changing this threshold could lead to a reduction of up to 28,000 heart attacks and 16,000 strokes each year.

NICE recommends that GPs start statin treatment for the primary prevention of CVD with atorvastatin 20 mg. Patients with established CVD, type 1 diabetes or type 2 diabetes should be offered a 80mg dose of atorvastatin.

Although the guidelines clearly state that lifestyle measures should be tried first, we are all fully aware of the difficulties the majority of our patients will have adhering to these. This means that most people with at least 10% CVD risk will need to take atorvastatin 10mg every day for the rest of their lives.

Some experts are very positive about these guidelines and state that there is plenty of evidence now available to support their use. In addition, they have been proven to be cost effective and have a favourable risk:benefit ratio.

Many GPs and healthcare professionals do not feel quite so positive about these guidelines. However, experts state that people should be encouraged to work out their QRISK2 score themselves, either online or via an App, rather than their GP working it out for them. Even if this is done, many more people are likely to need appointments to discuss the possibility of them being prescribed a statin.

The implementation of these guidelines could potentially create much more work to already very stretched primary care services. In addition, there are some real concerns about "medicalising" a nation and encouraging patients to take pills rather than change their unhealthy lifestyle. The BMA have even stated that these guidelines would "distort health spending priorities and disadvantage other patients".

I am personally concerned that the “worried-well” will be queuing at the surgery doors for their statins, whereas the overweight (or obese), sedentary smokers will disregard any perceived benefit of taking a statin and continue their unhealthy lifestyle regardless.

Author

Louise Newson

Louise is a part-time GP in Solihull, as well as a writer for numerous medical publications, including www.patient.co.uk. She is an Editor and Reviewer for e-learning courses for the RCGP. She is an Editor for Geriatric Medicine journal and the British Journal of Family Medicine. Louise has contributed to various healthcare articles in many different newspapers and magazines and is the spokesperson for The Information Standard. She has also done television and radio work. Louise is a medical consultant for Maverick TV and has participated regularly in ‘Embarrassing Bodies Live from the Clinic’. Louise has three young children and is married to a consultant urological surgeon. Although her spare time is limited she enjoys practising ashtanga yoga regularly and loves road cycling – she has raised over £2K for a local charity, Molly Olly Wishes by competing in a 120km cycle ride!

As a primary care professional, would you consider moving to an A&E site? (See OnMedica News 29/07)

Yes
No
Banner for OnMedica News
Binleys Guide
Wilmington Healthcare Limited, 6-14 Underwood Street, London, England, N1 7JQ
Copyright 2014 Wilmington Healthcare Limited
Registered in England and Wales, Reg No. 2530185
Twitter   Facebook
A Wilmington Company